A significant risk factor for heart failure, diabetes is a common debilitating comorbidity. New emerging therapies and a better understanding of this comorbid condition can assist clinicians in improving care and outcomes for these patients.

JACC: Heart Failure is focusing on the growing body of literature with a special issue on this topic planned for August of 2021. Submissions are due April 2, 2021.

Topics spanning this focus are welcome, including epidemiology, diagnosis and prognosis, short- and long-term outcomes, clinical management, phenotyping, emerging therapies, the role of biomarkers, and other relevant issues. Learn more.